- cafead   Jul 11, 2019 at 09:52: AM
via AbbVie remained the top pharma TV ad spender with Humira in June, and Gilead Sciences continued its TV push for Biktarvy and Truvada. But one long-time list placeholder dropped out of sight: Pfizer’s Xeljanz.
article source
article source